EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis Bloodstream Infections

Carly Loudermilk iD, Joshua Eudy, Stephanie Albrecht, Cara N Slaton, Stefanie Stramel, Patrick Tu iD, Benjamin Albrecht, Sarah B Green iD, Jeannette L Bouchard, Alison I Orvin iD, Christian F Caveness iD, Andrea Sikora Newsome iD und 2 weitere

Annals of Pharmacotherapy · 2025-02 · 59 (2) · 127-133

DOI: 10.1177/10600280241260146 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Pharmacotherapy, online erschienen am 17.06.2024. Verfasst von Carly Loudermilk und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, WellStar MCG Health, Augusta, GA, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, Enterococcus faecalis, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intravenous (IV) antibiotics have historically been considered standard of care for treatment of bloodstream infections (BSIs). Recent literature has shown sequential oral (PO) therapy to be noninferior to IV antibiotics for certain pathogens and disease states. However, a gap exists in the literature for BSI caused by Enterococcus faecalis.

Objective

To compare outcomes of definitive sequential PO therapy to definitive IV therapy in patients with E faecalis BSI.

Methods

Multicenter, retrospective, matched cohort study of adult patients with at least one blood culture positive for E faecalis from January 2017 to November 2022. Patients with polymicrobial BSI, concomitant infections requiring prolonged IV antibiotic therapy, those who did not receive antibiotic therapy, and those who died within 72 hours of index culture were excluded. Subjects were matched based on source of infection in a 2:1 (IV:PO) ratio. The primary outcome was a composite of all-cause mortality and treatment failure. Secondary outcomes included hospital length of stay (LOS), antibiotic duration, and 30-day readmission rate.

Results

Of the 186 patients who met criteria for inclusion, there was no statistically significant difference in the primary composite outcome for PO compared to IV therapy (14.5% vs 21.8%; OR 0.53 [0.23-1.25]) or 30-day readmission (17.5% vs 29%; OR 0.53 [0.25-1.13]). Hospital LOS was significantly longer in patients receiving IV-only therapy (6 days vs 14 days; P < 0.001). Conclusion and Relevance: Sequential oral therapy for E faecalis BSI had similar outcomes compared to IV-only treatment and may be considered in eligible patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacteremiaEnterococcus faecalisGram-Positive Bacterial InfectionsAdultAgedFemaleHumansMaleMiddle AgedAdministration, IntravenousAdministration, OralCohort StudiesLength of StayPatient ReadmissionRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

Enterococcus faecalisbloodstream infectionsequential oral therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, WellStar MCG Health, Augusta, GA, USA.
  • Department of Pharmacy, UofL Health, UofL Hospital, Louisville, KY, USA.
  • Department of Pharmacy, Orlando Health Orlando Regional Medical Center, Orlando, FL, USA.
  • Department of Pharmacy, Memorial Hermann Memorial City Medical Center, Houston, TX, USA.
  • Department of Pharmacy, Charlie Norwood VA Medical Center, Augusta, GA, USA.
  • Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA.

ORCID-Profile: Carly Loudermilk, Patrick Tu, Sarah B Green, Alison I Orvin, Christian F Caveness, Andrea Sikora Newsome, Christopher M Bland, Daniel T Anderson

Zitieren

APA

Loudermilk, C., Eudy, J., Albrecht, S., Slaton, C. N., Stramel, S., Tu, P., Albrecht, B., Green, S. B., Bouchard, J. L., Orvin, A. I., Caveness, C. F., Newsome, A. S., Bland, C. M., & Anderson, D. T. (2025). Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis Bloodstream Infections. Annals of Pharmacotherapy, 59(2), 127-133. https://doi.org/10.1177/10600280241260146

Vancouver

Loudermilk C, Eudy J, Albrecht S, Slaton CN, Stramel S, Tu P, et al. Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis Bloodstream Infections. Annals of Pharmacotherapy. 2025;59(2):127-133. doi:10.1177/10600280241260146

BibTeX
@article{Loudermilk2025,
  author = {Loudermilk, Carly and Eudy, Joshua and Albrecht, Stephanie and Slaton, Cara N and Stramel, Stefanie and Tu, Patrick and Albrecht, Benjamin and Green, Sarah B and Bouchard, Jeannette L and Orvin, Alison I and Caveness, Christian F and Newsome, Andrea Sikora and Bland, Christopher M and Anderson, Daniel T},
  title = {Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis Bloodstream Infections},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  volume = {59},
  number = {2},
  pages = {127--133},
  doi = {10.1177/10600280241260146}
}
Kostenlos starten →